• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Feds push states to abolishcertificate of need regs

Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

The U.S. Department of Justice and theFederal Trade Commission are pressuring stategovernments to repeal certificate of need lawsmeant to control healthcare costs by regulatingthe purchase of capital equipment, suchas MRI technology and CT scanners.

The U.S. Department of Justice and the Federal Trade Commission are pressuring state governments to repeal certificate of need laws meant to control healthcare costs by regulating the purchase of capital equipment, such as MRI technology and CT scanners.

The two agencies argue that CON laws are anticompetitive, favor incumbents, and undercut consumer choice. The DOJ and FTC underscored their position in discussions with Georgia and in statements to Alaska, Florida, and, more recently, Illinois.

At the invitation of Gov. Sarah Palin of Alaska, FTC officials testified in February at a state legislative committee in favor of HB 337, a bill that would have eliminated CON jurisdiction in several cities and towns. The bill's opponents say deregulation will favor privately owned specialty hospitals at the expense of the state's acute care hospitals. Efforts to pass the bill have so far been stymied.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.